These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 2142806

  • 41. Systemic chemotherapy in the management of advanced bladder cancer.
    Hall RR.
    Arch Esp Urol; 1990; 43 Suppl 2():193-6. PubMed ID: 2096778
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Neoadjuvant chemotherapy with docetaxel and cisplatin in patients with high-risk resectable bladder carcinoma: long term results.
    Bamias A, Deliveliotis C, Karayiannis A, Varkarakis I, Zervas I, Pantazopoulos D, Gika D, Dimopoulos MA.
    Eur Urol; 2004 Sep; 46(3):344-50; discussion 350-1. PubMed ID: 15306106
    [Abstract] [Full Text] [Related]

  • 44. [Neo-adjuvant (or preliminary) chemotherapy in cancer of the bladder. Evaluation].
    Charrot-Chinet P.
    Ann Urol (Paris); 1992 Sep; 26(1):25-9. PubMed ID: 1558369
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. [Complete remission of bone metastasis of bladder cancer treated by cisplatin-etoposide therapy].
    Tanaka S, Morikawa Y.
    Gan To Kagaku Ryoho; 1991 May; 18(6):1039-41. PubMed ID: 2029189
    [Abstract] [Full Text] [Related]

  • 48. [Adjuvant and neoadjuvant therapy in bladder and prostatic cancer].
    Goepel M, Otto T.
    Urologe A; 1992 Jul; 31(4):211-2. PubMed ID: 1514203
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Emmprin Expression Predicts Response and Survival following Cisplatin Containing Chemotherapy for Bladder Cancer: A Validation Study.
    Hemdan T, Malmström PU, Jahnson S, Segersten U.
    J Urol; 2015 Dec; 194(6):1575-81. PubMed ID: 26119672
    [Abstract] [Full Text] [Related]

  • 52. Effect of neoadjuvant chemotherapy on health-related quality of life in patients with muscle-invasive bladder cancer: results from JCOG0209, a randomized phase III study.
    Kitamura H, Hinotsu S, Tsukamoto T, Shibata T, Mizusawa J, Kobayashi T, Miyake M, Nishiyama N, Kojima T, Nishiyama H, Urologic Oncology Study Group of the Japan Clinical Oncology Group.
    Jpn J Clin Oncol; 2020 Dec 16; 50(12):1464-1469. PubMed ID: 32699909
    [Abstract] [Full Text] [Related]

  • 53. Which patients benefit the most from neoadjuvant chemotherapy in advanced bladder cancer?
    Niegisch G, Albers P.
    Curr Opin Urol; 2011 Sep 16; 21(5):434-9. PubMed ID: 21738037
    [Abstract] [Full Text] [Related]

  • 54. Neoadjuvant chemotherapy in bladder cancer: a randomized study. Nordic Cystectomy Trial I.
    Rintala E, Hannisdahl E, Fosså SD, Hellsten S, Sander S.
    Scand J Urol Nephrol; 1993 Sep 16; 27(3):355-62. PubMed ID: 8290916
    [Abstract] [Full Text] [Related]

  • 55. [Neoadjuvant chemotherapy of locally advanced tumors of the bladder: introduction].
    Mandressi A.
    Arch Ital Urol Nefrol Androl; 1990 Jun 16; 62(2):215-7. PubMed ID: 2142802
    [Abstract] [Full Text] [Related]

  • 56. Combination chemotherapy with intra-arterial cisplatin and doxorubicin plus intravenous methotrexate and vincristine for locally advanced bladder cancer. Kyushu University Urological and Radiological Oncology Group.
    Naito S, Kuroiwa T, Ueda T, Hasuo K, Masuda K, Kumazawa J.
    J Urol; 1995 Nov 16; 154(5):1704-9. PubMed ID: 7563327
    [Abstract] [Full Text] [Related]

  • 57. Organ reconstruction and conservation in bladder cancer.
    Pavone-Macaluso M.
    Prog Clin Biol Res; 1991 Nov 16; 370():143-5. PubMed ID: 1924443
    [No Abstract] [Full Text] [Related]

  • 58. Neoadjuvant chemotherapy versus cystectomy in management of stages II, and III urinary bladder cancer.
    Osman MA, Gabr AM, Elkady MS.
    Arch Ital Urol Androl; 2014 Dec 30; 86(4):278-83. PubMed ID: 25641451
    [Abstract] [Full Text] [Related]

  • 59. A European Organization for Research and Treatment of Cancer--Genitourinary Group phase 2 study of chemotherapy in stage T3-4N0-XM0 transitional cell cancer of the bladder: evaluation of clinical response.
    Splinter TA, Pavone-Macaluso M, Jacqmin D, Roberts JT, Carpentier P, de Pauw M, Sylvester R.
    J Urol; 1992 Dec 30; 148(6):1793-6. PubMed ID: 1433610
    [Abstract] [Full Text] [Related]

  • 60. Neoadjuvant and adjuvant chemotherapy for locally advanced bladder carcinoma: development of novel bladder preservation approach, Osaka Medical College regimen.
    Azuma H, Inamoto T, Takahara K, Ibuki N, Nomi H, Yamamoto K, Narumi Y, Ubai T.
    Int J Urol; 2012 Jan 30; 19(1):26-38. PubMed ID: 22077821
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.